Metraipolis › archive › dc_f6bfa9852bd8

Transdermal 17β-Estradiol for the Treatment of COVID-19: Protocol of an Early Terminated Phase 2 Randomized Controlled Trial — Europe PMC PMID:42726800

Source
Europe PMC (en)
Original
https://europepmc.org/article/MED/42726800
DOI
10.2196/81541
License (as archived)
solo-consultazione
Archived
2026-10-08T14:08:40.931Z
SHA-256 of the archived text
9613f3dc75af8c683ba84deb7e1e25ae33d318a0848dc169a3c6baced6fb0086
Stable URL of this page
https://metraipolis.com/documento/dc_f6bfa9852bd8

How to cite

Transdermal 17β-Estradiol for the Treatment of COVID-19: Protocol of an Early Terminated Phase 2 Randomized Controlled Trial — Europe PMC PMID:42726800 — Europe PMC (en), https://europepmc.org/article/MED/42726800 (solo-consultazione); archived copy: https://metraipolis.com/documento/dc_f6bfa9852bd8 (Metraipolis archive dc_f6bfa9852bd8, sha256 9613f3dc75af8c683ba84deb7e1e25ae33d318a0848dc169a3c6baced6fb0086)
BibTeX
@misc{dcf6bfa9852bd8,
  title = {Transdermal 17β-Estradiol for the Treatment of COVID-19: Protocol of an Early Terminated Phase 2 Randomized Controlled Trial — Europe PMC PMID:42726800},
  howpublished = {Europe PMC (en)},
  url = {https://europepmc.org/article/MED/42726800},
  note = {License solo-consultazione; archived copy https://metraipolis.com/documento/dc_f6bfa9852bd8; sha256 9613f3dc75af8c683ba84deb7e1e25ae33d318a0848dc169a3c6baced6fb0086},
  year = {2026}
}

Archived text

The text is not reproduced here: the archive holds it as solo-consultazione (consultation only, no republication). Read it at the original source: https://europepmc.org/article/MED/42726800. Agents can read the archived copy with the MCP tool read_document.